vilanterol Articles

GSK pays $7.5 million milestone to Isis Pharma under antisense deal; says FDA accepts Anoro Ellipta NDA

20 February 2013

GlaxoSmithKline and Theravance file for EU approval of UMEC/VI for COPD

10 January 2013

US FDA accepts GSK and Theravance NDA for FF/VI; COPD drug filed in Japan

27 September 2012

GSK completes LAMA/LABA Ph III program; readies for global filings

28 August 2012

Positive new Ph III data from GlaxoSmithKline and Theravance on UMEC/VI

2 July 2012

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end